# FDA Approves Bemotrizinol, a Sunscreen Ingredient With Decades of International Safety Data
The FDA has approved bemotrizinol, a new UV-filtering ingredient for American sunscreens. European and Asian markets have used this ingredient safely for years, making it a tested option for U.S. families seeking sun protection.
Bemotrizinol works as a broad-spectrum filter, protecting skin from both UVA and UVB rays. The ingredient absorbs UV radiation and converts it into heat, similar to how other chemical sunscreen actives function. Because it has been used extensively overseas, manufacturers and dermatologists already understand its performance and safety profile.
The approval expands options for parents shopping for sunscreen. Families previously limited to existing FDA-approved ingredients like oxybenzone, avobenzone, and zinc oxide now have an additional choice. This matters because some children develop sensitivities to specific sunscreen actives. More options mean better chances of finding a formula that works for each child's skin.
Bemotrizinol's approval follows FDA review of safety data gathered from years of international use. The ingredient has shown stability in formulations and reliable UV protection across multiple studies. For families, this means the ingredient arrives with extensive real-world testing already completed.
Parents should note that sun protection remains about consistent application and reapplication, not just ingredient choice. The American Academy of Pediatrics recommends applying broad-spectrum sunscreen with SPF 30 or higher to children older than six months. Reapplication every two hours, or immediately after swimming, protects skin effectively.
This approval reflects the FDA's willingness to evaluate globally-used ingredients when safety data supports their use. Families looking for sunscreen alternatives now have more flexibility in finding products that fit their skin types and preferences. As always, selecting any sunscreen remains better